TippingPoint Biosciences
ActiveFirst ever therapeutics for cancers driven by aberrant chromatin networks
What it does
Pioneering new therapies for diseases of chromatin dysfunction. There is a necessity for new types of treatments in diseases like Pediatric Diffuse Midlines Glioma (DMG). Cancer, Chromatin, Health, new solutions.
How it has moved
- 2026-04-01 · seed · $4.5M
TippingPoint Biosciences raised $4.5M in seed funding to advance its bioscience research and development. source
Next to it in Healthcare and bio · Cancer therapeutics via chromatin networks
- Humane GenomicsY Combinator S21
A platform to make artificial viruses as cancer therapeutics.
- SFA TherapeuticsY Combinator S21
Regulating the immune system to block cancer & autoimmune diseases
- AOA DxY Combinator S21
Blood Test for Early Detection of Ovarian Cancer
- DigistainY Combinator S21
Pioneering Breast Cancer Diagnostics for a Healthier Tomorrow
- MatrubialsY Combinator S21
Developing milk-inspired therapeutics for infectious diseases
- Promakhos TherapeuticsY Combinator S21
A therapeutics platform for curing inflammatory disorders
- ViAn TherapeuticsSOSV SOSV IndieBio SF 14
Topical antiangiogenic peptide for retinal vascular diseases
- FREZENT Biological SolutionsSOSV SOSV IndieBio NY 07
Changing the prognosis for patients with advanced stage cancer